Biodyne Co., Ltd. (KOSDAQ:314930)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,360.00
-140.00 (-1.65%)
At close: Jul 16, 2026
Market Cap243.77B -43.5%
Revenue (ttm)6.98B +33.3%
Net Income1.44B
EPS48.72
Shares Out 29.48M
PE Ratio169.76
Forward PE55.78
Dividendn/a
Ex-Dividend Daten/a
Volume28,858
Open8,420.00
Previous Close8,500.00
Day's Range8,270.00 - 8,650.00
52-Week Range7,540.00 - 16,860.00
Beta1.05
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Biodyne

Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314930
Full Company Profile

Financial Performance

Financial Statements